Insys Therapeutics Inc.’s legal woes worsened Thursday when the state of Arizona filed a lawsuit claiming the company improperly marketed a powerful opioid painkiller. Arizona’s attorney general, Mark Brnovich, alleged in a suit filed early Thursday morning that Insys engaged in a fraudulent marketing scheme to boost sales of its drug Subsys, a prescription mouth-spray formulation of fentanyl. Insys and its former employees...

Source: Wall Street Journal August 31, 2017 14:39 UTC